Literature DB >> 22553537

MMP-2 gene polymorphisms in type 2 diabetes mellitus diabetic retinopathy.

Jie Yang1, Xiao-Hui Fan, Yong-Qing Guan, Yan Li, Wei Sun, Xin-Zhi Yang, Rui Liu.   

Abstract

AIM: To study the association between polymorphisms of the MMP-2 gene and diabetic retinopathy (DR).
METHODS: MMP-2 C-1306T and C-735T SNPs was genotyped by polymerase chain reaction-restrictive fragment length polymorphism (PCR-RFLP) analysis in 151 DR patients and 150 healthy individuals served as control.
RESULTS: There is no significant difference between the patient and control groups in allele or genotype distributions of MMP-2 C-735T (P=0.263 and P=0.248). Also, there is no significant difference between the patient and control in allele of MMP-2 C-1306T (P=0.03). However the result has significant deviation of C/C, C/T, T/T genotypic frequencies between the patient and control groups in MMP-2 C-1306T (P=0.008). We found that subjects with the MMP-2 C-1306T genotype had an overall 2-fold increase in the risk of developing DR [adjusted odds ratio (OR)=2.446; 95% confidence interval (CI)=1.239-4.829] compared with those with the T-1306T or C-1306T genotype. Stratification analysis showed that the MMP-2 -1306C/T and -735C/T SNPs are not associated with the development of NPDR to PDR of DR in North Chinese Han population.
CONCLUSION: MMP-2 C-1306T genotypes may be associated with DR development in the Chinese population. However, there is no relationship between the MMP-2 C-735T genotypes with the development of DR.

Entities:  

Keywords:  MMP-2; diabetic retinopathy; gene; single nucleotide polymorphism

Year:  2010        PMID: 22553537      PMCID: PMC3340781          DOI: 10.3980/j.issn.2222-3959.2010.02.10

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

1.  Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.

Authors:  Jérôme Rollin; Sandra Régina; Patrick Vourc'h; Sophie Iochmann; Claire Bléchet; Pascale Reverdiau; Yves Gruel
Journal:  Lung Cancer       Date:  2007-01-08       Impact factor: 5.705

Review 2.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

3.  The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells.

Authors:  H Qin; Y Sun; E N Benveniste
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

Review 4.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

5.  Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.

Authors:  Yifeng Zhou; Chunyuan Yu; Xiaoping Miao; Yonggang Wang; Wen Tan; Tong Sun; Xuemei Zhang; Ping Xiong; Dongxin Lin
Journal:  Carcinogenesis       Date:  2005-02-24       Impact factor: 4.944

6.  Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.

Authors:  S J Price; D R Greaves; H Watkins
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

7.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

8.  Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians.

Authors:  A E Hegab; T Sakamoto; Y Uchida; A Nomura; Y Ishii; Y Morishima; M Mochizuki; T Kimura; W Saitoh; T Kiwamoto; T Iizuka; H H Massoud; H M Massoud; K M Hassanein; K Sekizawa
Journal:  Respir Med       Date:  2005-01       Impact factor: 3.415

9.  Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.

Authors:  Chunyuan Yu; Yifeng Zhou; Xiaoping Miao; Ping Xiong; Wen Tan; Dongxin Lin
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

10.  Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.

Authors:  J Gilabert-Estellés; A Estellés; J Gilabert; R Castelló; F España; C Falcó; A Romeu; M Chirivella; E Zorio; J Aznar
Journal:  Hum Reprod       Date:  2003-07       Impact factor: 6.918

View more
  3 in total

Review 1.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

Review 2.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

Review 3.  Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications.

Authors:  Beata Gajewska; Mariola Śliwińska-Mossoń
Journal:  Int J Mol Sci       Date:  2022-09-12       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.